NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 312 filers reported holding NOVAVAX INC in Q3 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,238 | -62.6% | 31,386 | -61.7% | 0.00% | – |
| Q2 2023 | $608,191 | +104.8% | 81,856 | +183.0% | 0.00% | – |
| Q4 2022 | $297,000 | -97.6% | 28,924 | -87.9% | 0.00% | -100.0% |
| Q2 2022 | $12,304,000 | +319.1% | 239,251 | +498.0% | 0.00% | +300.0% |
| Q1 2022 | $2,936,000 | -93.1% | 40,007 | -86.6% | 0.00% | -91.7% |
| Q4 2021 | $42,541,000 | +97.5% | 298,316 | +187.0% | 0.01% | +71.4% |
| Q3 2021 | $21,536,000 | -84.1% | 103,940 | -83.7% | 0.01% | -83.3% |
| Q2 2021 | $135,411,000 | +24.6% | 638,088 | +6.5% | 0.04% | +16.7% |
| Q1 2021 | $108,693,000 | +12.4% | 599,410 | -30.9% | 0.04% | +5.9% |
| Q4 2020 | $96,739,000 | +45.3% | 867,560 | +41.2% | 0.03% | +25.9% |
| Q3 2020 | $66,567,000 | +1537.6% | 614,367 | +1159.8% | 0.03% | +1250.0% |
| Q2 2020 | $4,065,000 | +2183.7% | 48,767 | +271.6% | 0.00% | – |
| Q1 2020 | $178,000 | – | 13,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |